Utility of an In-Vitro Micro-Neutralizing Test in Comparison to a Plaque Reduction Neutralization Test for Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Serology and Drug Screening
Pathogens · 2023
DOI: 10.3390/pathogens13010008 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pathogens, 2023. Verfasst von Kazumi Haga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Medical Sciences, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan. Hauptthemen laut MEDLINE: Zika Virus, Encephalitis Virus, Japanese, Neutralization Tests, Antibodies, Viral. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Flavivirus infections, including dengue virus (DENV), Japanese encephalitis virus (JEV), and Zika virus (ZIKV), present significant global public health challenges. For successful vaccine design, the assessment of neutralizing antibody activity requires reliable and robust methodologies for determining antibody titers. Although the plaque reduction neutralization test (PRNT) is commonly acknowledged as the gold standard, it has limitations in terms of time and cost, and its usage may be limited in resource-limited settings. To address these challenges, we introduced the micro-neutralization test (MNT) as a simplified alternative to the PRNT. The MNT employs a 96-well plate format, conducts microscale neutralization assays, and assesses cell viability by dissolving cells to create a uniform color solution, which is measured with a spectrometer. In this study, we evaluated the utility of the MNT by contrasting the end-point titers of the MNT and PRNT using 4 monoclonal antibodies, 15 non-human primate serum samples, and 2 therapeutic drug candidates across flaviviruses. The results demonstrated a strong correlation between the MNT and PRNT titers, affirming the robustness and reproducibility of the MNT for evaluating control measures against flaviviruses. This research contributes valuable insights toward the development of a cost-effective antibody titer testing approach that is particularly suitable for resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Developmental Medical Sciences, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
- Department of Biology, Emory College of Art and Science, Emory University, Atlanta, GA 30322, USA.
ORCID-Profile: Misao Himeno, Meng Ling Moi
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Haga, K., Chen, Z. N., Himeno, M., Majima, R., & Moi, M. L. (2023). Utility of an In-Vitro Micro-Neutralizing Test in Comparison to a Plaque Reduction Neutralization Test for Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Serology and Drug Screening. Pathogens. https://doi.org/10.3390/pathogens13010008
Vancouver
Haga K, Chen ZN, Himeno M, Majima R, Moi ML. Utility of an In-Vitro Micro-Neutralizing Test in Comparison to a Plaque Reduction Neutralization Test for Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Serology and Drug Screening. Pathogens. 2023. doi:10.3390/pathogens13010008
BibTeX
@article{Haga2023,
author = {Haga, Kazumi and Chen, Zhenying Nancy and Himeno, Misao and Majima, Ryuichi and Moi, Meng Ling},
title = {Utility of an In-Vitro Micro-Neutralizing Test in Comparison to a Plaque Reduction Neutralization Test for Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Serology and Drug Screening},
journal = {Pathogens},
year = {2023},
doi = {10.3390/pathogens13010008}
}
EUVIMED